Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan/HCTZ for Severe Hypertension
NCT00095394Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of irbesartan, hydrochlorothiazide in hypertension (HTN), sponsored by Bristol Myers Squibb. Started Sep 2004; status: completed.
02
Drugs
irbesartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00095394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095394.